statistiche ricercatore

DENTALI, FRANCESCO

Distribuzione geografica

Continente	#
NA - Nord America	25.199
EU - Europa	13.671
AS - Asia	3.594
SA - Sud America	56
Continente sconosciuto - Info sul continente non disponibili	33
OC - Oceania	11
AF - Africa	8
Totale	42.572

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	25.152
IT - Italia	6.971
UA - Ucraina	2.279
TR - Turchia	1.610
SE - Svezia	1.186
IE - Irlanda	798
DE - Germania	792
VN - Vietnam	732
CN - Cina	702
FI - Finlandia	523
GB - Regno Unito	430
SG - Singapore	420
RU - Federazione Russa	335
FR - Francia	195
IN - India	45
CA - Canada	41
BR - Brasile	36
JP - Giappone	30
EU - Europa	29
BE - Belgio	27
NL - Olanda	27
CZ - Repubblica Ceca	17
CL - Cile	11
AU - Australia	10
ES - Italia	9
LT - Lituania	9
CH - Svizzera	8
GR - Grecia	8
PT - Portogallo	8
RO - Romania	8
IR - Iran	7
PL - Polonia	7
AT - Austria	6
HK - Hong Kong	5
AL - Albania	4
AR - Argentina	4
HU - Ungheria	4
ID - Indonesia	4
PH - Filippine	4
RS - Serbia	4
TH - Thailandia	4
A2 - ???statistics.table.value.countryCode.A2???	3
AE - Emirati Arabi Uniti	3
EG - Egitto	3
IL - Israele	3
KR - Corea	3
MK - Macedonia	3
MX - Messico	3
MY - Malesia	3
NO - Norvegia	3
PK - Pakistan	3
BD - Bangladesh	2
BO - Bolivia	2
DK - Danimarca	2
HN - Honduras	2
KW - Kuwait	2
LI - Liechtenstein	2
LK - Sri Lanka	2
PE - Perù	2
SI - Slovenia	2
TW - Taiwan	2
A1 - Anonimo	1
AM - Armenia	1
AO - Angola	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
CR - Costa Rica	1
DZ - Algeria	1
EC - Ecuador	1
IQ - Iraq	1
JO - Giordania	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LV - Lettonia	1
MA - Marocco	1
MD - Moldavia	1
NG - Nigeria	1
NZ - Nuova Zelanda	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
UZ - Uzbekistan	1
ZA - Sudafrica	1
Totale	42.572

Salva come PNG Salva come JPEG

Città	#
Milan	5.038
Fairfield	4.108
Woodbridge	2.671
Ashburn	2.028
Houston	1.922
Jacksonville	1.808
Seattle	1.604
Wilmington	1.492
Chandler	1.387
Cambridge	1.384
Ann Arbor	1.312
Izmir	813
Dublin	793
Princeton	787
Dearborn	591
Nyköping	539
Boardman	498
Singapore	390
Dong Ket	367
Rome	323
San Diego	243
San Mateo	159
Ogden	152
Beijing	129
Como	127
Chicago	120
Washington	102
London	101
Santa Clara	82
New York	74
Düsseldorf	70
Helsinki	69
Hefei	63
Redmond	62
Los Angeles	61
Nanjing	59
Norwalk	53
Kunming	51
Verona	50
Kocaeli	39
Munich	38
Paris	38
Dallas	31
Frankfurt am Main	30
Jinan	30
Kilburn	30
Toronto	29
Guangzhou	24
Nanchang	24
Tokyo	24
Brussels	22
Besana In Brianza	20
Falls Church	19
Ponte Lambro	19
Redwood City	19
Prescot	18
Fuzhou	17
Chiswick	16
Varese	16
Brno	15
Shenyang	15
Acton	14
Berlin	14
Indiana	14
Philadelphia	13
Zhengzhou	13
Bergamo	12
Hounslow	12
Changsha	11
San Francisco	11
São Paulo	11
Wandsworth	11
Wuhan	11
Busto Arsizio	10
Genoa	10
Hebei	10
New Bedfont	10
Pune	10
Southwark	10
Xian	10
Islington	9
Legnano	9
Parma	8
Phoenix	8
Ralingen	8
Suresnes	8
Brescia	7
Chongqing	7
Hangzhou	7
Magnago	7
Ningbo	7
Tianjin	7
Torino	7
Abbiategrasso	6
Detroit	6
Florence	6
Lappeenranta	6
Saint Louis	6
Shanghai	6
Amsterdam	5
Totale	32.572

Salva come PNG Salva come JPEG

Nome	#
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis	238
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery	227
Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature	227
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	223
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency vka anticoagulation reversal	220
Risk of recurrence of unusual site venous thromboembolism	214
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	205
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study	204
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature	199
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	196
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry	194
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome	194
Optimal treatment duration of venous thrombosis	191
incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.	190
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism	187
Patient selection for thromboprophylaxis in medical inpatients	186
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis.	186
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study	186
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.	180
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable?	180
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice	180
Venous ischemic syndromes	180
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature	179
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis	178
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data	177
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis	175
Warfarin interactions with antibiotics in the ambulatory care setting	174
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation	172
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens	171
Duration of anticoagulation after venous thromboembolism in real world clinical practice	170
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism	170
Venous and arterial thrombosis in patients with HIV infection	169
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis	169
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy	169
Seasonal and monthly variation in occurrence of hypertensive urgency	168
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis	165
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation	165
ABO blood group and vascular disease: an update	164
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature	164
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	163
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation.	163
Statins and secondary prevention of ischemic and hemorrhagic stroke	162
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature	162
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding	161
Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians	161
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study	160
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment	158
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage	158
Is diabetes a hypercoagulable state? A critical appraisal	158
Low-molecular -weight heparin in pregnancies after ART -A retrospective study-	158
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree?	157
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study	157
sRAGE and early signs of cardiac target organ damage in mild hypertensives	157
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension.	156
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs	156
The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature	155
Prevention of in-hospital VTE: why can't we do better?	154
In vitro effects of Apixaban on 5 different cancer cell lines	154
The role of thrombolytic therapy in pulmonary embolism	153
Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events	153
How I treat splanchnic vein thrombosis	152
Statins for acute ischemic stroke	152
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal	151
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.	150
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis.	149
Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE Study	149
Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism: Comment	149
In-hospital mortality due to pulmonary embolism in patients with Alzheimer disease: A sex effect?	149
The effect of thyroid autoantibodies on warfarin stability	149
Italian intersociety consensus on DOAC use in internal medicine	147
Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience	146
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes	146
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: Results of a patient-level meta-analysis	146
Direct oral anticoagulants for superficial-vein thrombosis	146
The prevention and treatment of venous thromboembolism in pregnancy	146
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism.	145
Management of hypertension in overweight and obese patients: a practical guide for clinicians.	145
Clinical Pregnancies and Live Births in women approaching ART: a follow-up analysis of 157 women after thrombophilia screening	145
Neutrophil-to-lymphocyte ratio: A new prognostic factor even in patients with heart failure	144
A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism	144
Inferior vena cava filter in patients with venous thromboembolism and major bleeding events: building the evidence	144
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	144
Risk of Thromboembolism, Recurrent Hemorrhage, and Death after Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding	144
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases	143
Antithrombin levels and the risk of a first episode of venous thromboembolism: a case-control study	143
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy	143
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study	142
A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.	142
Nonadherence with INR monitoring and anticoagulant complications	142
Venous thromboembolism and arterial thromboembolism. Many similarities, far beyond thrombosis per se.	140
Natural anticoagulants deficiency and the risk of venous thromboembolism: A meta-analysis of observational studies	140
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.	139
Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study.	139
Statins, fibrates, and venous thromboembolism: a meta-analysis.	139
Short-term prognosis of intracranial haemorrhage in patients on oral anticoagulant or antiplatelet drugs	138
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism: A multicentre retrospective cohort study	138
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature	138
Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging.	137
5 flourouracil-induced apical ballooning syndrome: a case report.	137
The role of the metabolic syndrome in patients with provoked venous thromboembolic events	137
Totale	16.361

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	187.694
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	187.694

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	5.196	0	0	0	0	0	965	1.231	1.043	721	571	169	496
2020/2021	7.056	145	653	766	695	409	732	291	619	838	458	574	876
2021/2022	4.033	403	544	187	104	219	172	325	215	229	726	411	498
2022/2023	4.395	480	206	318	379	303	956	14	577	652	247	141	122
2023/2024	8.254	1.250	1.289	1.290	1.568	1.646	576	66	120	242	96	43	68
2024/2025	2.051	46	52	1.126	179	237	411	0	0	0	0	0	0
Totale													43.094